ROYAL BANK OF CANADA - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 32 filers reported holding ATYR PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2019$017
-67.3%
0.00%
Q1 2019$0520.0%0.00%
Q4 2018$0520.0%0.00%
Q3 2018$052
+477.8%
0.00%
Q3 2017$09
+28.6%
0.00%
Q1 2017$0
-100.0%
7
-97.9%
0.00%
Q3 2015$3,000
-62.5%
331
-19.5%
0.00%
Q2 2015$8,0004110.00%
Other shareholders
ATYR PHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$6,215,0006.43%
EcoR1 Capital, LLC 2,292,659$7,795,0001.38%
Rock Springs Capital Management LP 475,000$1,615,0000.08%
Quotient Investors, LLC 22,200$77,0000.06%
Alyeska Investment Group, L.P. 839,264$2,853,0000.02%
RIVERHEAD CAPITAL MANAGEMENT LLC 79,677$275,0000.01%
Glen Harbor Capital Management LLC 153,238$529,0000.01%
Elkfork Partners LLC 99,154$342,0000.01%
Meadow Creek Investment Management LLC 126,196$435,0000.01%
Tyers Asset Management LLC 72,112$249,0000.01%
View complete list of ATYR PHARMA INC shareholders